Practice question

Answer the question and get instant feedback.

EasyEndocrinologyType 2 Diabetes Mellitusmrcgp aktukmlapaneprescribing safety assessment

A 67-year-old man with a new diagnosis of type 2 diabetes has an HbA1c of 58 mmol/mol (7.5%). He has a BMI of 31 kg/m$^2$ and no cardiovascular comorbidities or renal impairment. According to NICE NG28, what is the most appropriate initial pharmacological agent to offer?

Educational content. Not a substitute for clinical judgement or local policy.